This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kinzler, K. W. & Vogelstein, B. Cell 87, 159–170 (1996).
Hahn, W. C. et al. Nature 400, 464–468 (1999).
Hayflick, L. & Moorhead, P. S. Exp. Cell Res. 37, 614–636 (1965).
Land, H., Parada, L. F. & Weinberg, R. A. Nature 304, 596–602 (1983).
Rassoulzadegan, M. et al. Nature 300, 713–718 (1982).
Ruley, H. E. Nature 304, 602–606 (1983).
Meyerson, M. et al. Cell 90, 785–795 (1997).
Kiyono, T. et al. Nature 396, 84–88 (1998).
Bodnar, A. G. et al. Science 279, 349–352 (1998).
Counter, C. M. et al. Proc. Natl Acad. Sci. USA 95, 14723–14728 (1998).
Morales, C. P. et al. Nature Genet. 21, 115–118 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weitzman, J., Yaniv, M. Rebuilding the road to cancer. Nature 400, 401–402 (1999). https://doi.org/10.1038/22637
Issue Date:
DOI: https://doi.org/10.1038/22637
This article is cited by
-
Canis familiaris telomerase reverse transcriptase undergoes alternative splicing
Mammalian Genome (2008)
-
Are oncoantigens suitable targets for anti-tumour therapy?
Nature Reviews Cancer (2007)
-
Use of human tissue to assess the oncogenic activity of melanoma-associated mutations
Nature Genetics (2005)
-
Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy
Leukemia (2003)